This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Nora Zizlsperger: Innovator in Immunoglobulin Fusion Proteins
Introduction
Nora Zizlsperger is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of immunology through her innovative work on immunoglobulin fusion proteins. Her research focuses on developing novel therapeutic approaches for cancer treatment.
Latest Patents
Nora Zizlsperger holds a patent for SIRP-α immunoglobulin fusion proteins. This invention discloses immunoglobulin fusion proteins designed to bind both CD47 and a tumor cell antigen. The immunoglobulin fusion proteins include a SIRP-α moiety that binds CD47 and an antigen binding site for a tumor cell antigen. This patent represents a significant advancement in targeted cancer therapies.
Career Highlights
Nora Zizlsperger is currently associated with Merck Patent GmbH, where she continues to push the boundaries of scientific research. Her work has garnered attention for its potential impact on cancer treatment and immunotherapy.
Collaborations
Nora has collaborated with notable colleagues, including Kin-Ming Lo and Aroop Sircar. These partnerships have enhanced her research and contributed to the development of innovative solutions in the field.
Conclusion
Nora Zizlsperger is a trailblazer in the field of immunology, with her patent on SIRP-α immunoglobulin fusion proteins showcasing her innovative spirit. Her contributions to cancer research are paving the way for future advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile